Black Hawk Acquisition Corporation
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Market Cap
$50.4M
Cash Runway
4.9 mo
Lead Asset
idss forcetriad control module
Next Catalyst
—
Tracking 2 pipeline candidates for Black Hawk Acquisition Corporation · Updated within the last hour.
Go deeper on Black Hawk Acquisition Corporation with Spotter
Ask follow-up questions and run a full multi-agent deep dive on BKHA — live, with citations.
Score breakdownBased on 3 of 6 signals · derived from public data
4.9 months
OCF -$110K · Net income $140K
No tracked pipeline phase
2 candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Key Financialsas of February 28, 2026
Cash
$178K
Quarterly Burn
$110K
Free Cash Flow
-$110K
Total Liabilities
$4.7M
Shareholders Equity
-$4.5M
Current Ratio
0.08
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| idss forcetriad control module | — |
| idss slc | — |
Commercialization & Governance
Commercialization
- Partnerships
- Continental Stock Transfer & Trust Company (trustee and transfer agent); Sponsor (private placement purchaser and founder shareholder); Nasdaq (listing venue); underwriters (granted over-allotment option); BEEC Capital and BEEC Inc. (affiliates/companies associated with management members).
- Launch Markets
- United States
- Commercial Strategy
- Operate as a publicly listed acquisition company (SPAC) that acquires a target business and provides the target with an alternative to a traditional IPO by providing access to U.S. capital markets, a public listing, and a platform for existing management to leverage the acquirer's management team. The company intends to add value by improving operational efficiency, scaling revenue organically and/or via acquisitions, and providing greater certainty and lower cost relative to a traditional IPO. The company will seek targets that will benefit from being publicly traded and can utilize access to broader capital sources and the public profile associated with a public company.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
20
Total value held
$17.9M
| Holder | Shares | Value |
|---|---|---|
| mizuho securities usa llc | 373,800 | $4.3M |
| wolverine asset management llc | 340,810 | $3.9M |
| berkley w r corp | 309,134 | $3.6M |
| boothbay fund management, llc | 120,000 | $1.4M |
| meteora capital, llc | 89,000 | $1.0M |
| d. e. shaw & co., inc. | 75,000 | $866K |
| warberg asset management llc | 72,323 | $841K |
| crossingbridge advisors, llc | 53,024 | $615K |
| polar asset management partners inc. | 39,100 | $453K |
| rlh capital llc | 29,448 | $342K |
Showing top 10 of 20 institutional holders of Black Hawk Acquisition Corporation. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
Who is the CEO of Black Hawk Acquisition Corporation?
Mr. Kent Louis Kaufman is the chief executive officer of Black Hawk Acquisition Corporation (BKHA).
Where is Black Hawk Acquisition Corporation headquartered?
Black Hawk Acquisition Corporation (BKHA) is headquartered in Danville, CA, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on Black Hawk Acquisition Corporation
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.